Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Postpartum dexamethasone for HELLP syndrome
ACTRN12610001007022Phase 4Completed
- Sponsor
- Universitas Academic Hospital
- Start
- Oct 2008
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of dexamethasone in HELLP syndrome (HELLP) (2 arms), sponsored by Universitas Academic Hospital. Primary endpoints: Days in hospital, Days until platelet count exceeds 100,000/mm3 and 1 more. Started Oct 2008; status: completed.
02
Drugs
dexamethasone
03
Conditions
HELLP syndrome (HELLP)
Beyond the preview
Go deeper on ACTRN12610001007022.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12610001007022.